共 78 条
[1]
Punthakee Z(2018)Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome Can J Diabetes 42 S10-S15
[2]
Goldenberg R(2018)Vasopressin and diabetic kidney disease Ann Nutr Metab 72 17-20
[3]
Katz P(2004)From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines Endocr Rev 25 971-1010
[4]
El Boustany R(2001)Vasopressin and diabetes mellitus Nephron 87 8-18
[5]
Schrijvers BF(1985)Regulation of plasma vasopressin in insulin-dependent diabetes mellitus Am J Physiol 249 E317-E325
[6]
De Vriese AS(2017)Vasopressin and diabetic nephropathy Curr Opin Nephrol Hypertens 26 311-318
[7]
Flyvbjerg A(2016)Increased levels of copeptin, a surrogate marker of arginine vasopressin, are associated with an increased risk of chronic kidney disease in a general population Am J Nephrol 44 22-28
[8]
Bankir L(2013)Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria Diabetes Care 36 3639-3645
[9]
Bardoux P(2013)Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33) Diabetologia 56 1680-1688
[10]
Ahloulay M(2015)Association between copeptin and declining glomerular filtration rate in people with newly diagnosed diabetes. The Skaraborg Diabetes Register J Diabetes Complications 29 1062-5